BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17768016)

  • 1. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia.
    Lim K; Chan P; Dinniwell R; Fyles A; Haider M; Cho YB; Jaffray D; Manchul L; Levin W; Hill RP; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):126-33. PubMed ID: 17768016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
    Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of tumor repopulation on radiotherapy planning.
    Wang JZ; Li XA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-volume simulation during radiotherapy for head-and-neck cancer using a four-level cell population model.
    Chvetsov AV; Dong L; Palta JR; Amdur RJ
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):595-602. PubMed ID: 19596173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further radiobiologic modeling of palliative radiotherapy: use of virtual trials.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):221-9. PubMed ID: 17707276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor regression dynamics with external radiotherapy in cancer cervix and its implications.
    Datta NR; Rajkumar A; Basu R
    Indian J Cancer; 2004; 41(1):18-24. PubMed ID: 15105575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
    Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical tumor dimensions may be useful to prevent geographic miss in conventional radiotherapy of uterine cervix cancer-a magnetic resonance imaging-based study.
    Justino PB; Baroni R; Blasbalg R; Carvalho Hde A
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):503-10. PubMed ID: 18947939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
    Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.
    Barker JL; Garden AS; Ang KK; O'Daniel JC; Wang H; Court LE; Morrison WH; Rosenthal DI; Chao KS; Tucker SL; Mohan R; Dong L
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):960-70. PubMed ID: 15234029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.
    Rofstad EK; Sundfør K; Lyng H; Tropé CG
    Br J Cancer; 2000 Aug; 83(3):354-9. PubMed ID: 10917551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment tumour volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer.
    Soutter WP; Hanoch J; D'Arcy T; Dina R; McIndoe GA; DeSouza NM
    BJOG; 2004 Jul; 111(7):741-7. PubMed ID: 15198766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI for cervical cancer not only correlates with tumor hypoxia, but also predicts ultimate outcome: in regard to Lim et al. (Int J Radiat Oncol Biol Phys 2008;70:126-133).
    Wang JZ; Mayr NA; Zhang D; Yuh WT
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1602-3; author reply 1603. PubMed ID: 18640508
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of patients age, type of tumor growth, hematocrit, and radiation-induced tumor regression on the prognosis of advanced uterine cervix carcinoma.
    Boljesíková E; Gyárfásová M; Durkovský J
    Neoplasma; 1988; 35(4):435-41. PubMed ID: 3185840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
    Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
    Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.